InsiderClue
Stocks · Consumer discretionary · Apparel & Other Finishd Prods of Fabrics & Similar Matl

Ping An Biomedical Co., Ltd.

PASW Clue Score25
Cayman Islands CIK 0001897532
$0.12 +1.07% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.12 −20.40% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 9 Jun 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue82.6Operating income0.6Net income−1.0EPS, diluted−0.06Fiscal year 2024Revenue87.6 +6.1%Operating income−0.0Net income−1.3EPS, diluted−0.07Fiscal year 2025Revenue34.1 −61.0%Operating income−14.7Net income−12.8EPS, diluted−0.69
FY2023FY2024FY2025
Revenue 82.6 87.6 34.1
Growth +6.1% −61.0%
Operating income 0.6 −0.0 −14.7
Net income −1.0 −1.3 −12.8
Growth
EPS, diluted −0.06 −0.07 −0.69
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Gross margin5.1%Operating margin0.7%Net margin−1.2%Fiscal year 2024Gross margin6.2%Operating margin−0.0%Net margin−1.5%Fiscal year 2025Gross margin2.8%Operating margin−43.1%Net margin−37.6%
FY2023FY2024FY2025
Gross margin 5.1% 6.2% 2.8%
Operating margin 0.7% −0.0% −43.1%
Net margin −1.2% −1.5% −37.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2023Operating cash flow−6.1Dividends paid−9.6Fiscal year 2024Operating cash flow14.6Dividends paid−0.3Fiscal year 2025Operating cash flow−6.4
FY2023FY2024FY2025
Operating cash flow −6.1 14.6 −6.4
Dividends paid −9.6 −0.3 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash0.6Shareholders’ equity−5.9Fiscal year 2024Cash0.1Shareholders’ equity−7.2Fiscal year 2025Cash1.2Shareholders’ equity45.2
FY2023FY2024FY2025
Cash 0.6 0.1 1.2
Shareholders’ equity −5.9 −7.2 45.2

In millions of CNY, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of CNY, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 30 Sep 2023 FY2024 30 Sep 2024 FY2025 30 Sep 2025
Revenue and profit
82.6 87.6 34.1
Growth +6.1% −61.0%
78.3 82.2 33.2
4.2 5.4 0.9
Growth +27.8% −82.5%
3.3 5.0 6.0
0.6 −0.0 −14.7
Growth −100.3%
0.0 −0.7 −14.7
−1.0 −0.6 1.9
−1.0 −1.3 −12.8
Growth
Per share
−0.06 −0.07 −0.69
−0.06 −0.07 −0.69
Growth
18.0 18.0 18.5
18.0 18.0 18.5
Growth +0.0% +2.7%

Shown in CNY as filed; the screener converts to dollars.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 3 of 3 years on file.